Hyperbranched Polylysine Nanoparticle Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nucleic acid carriers, such as viruses and some cationic polymers, face challenges with high cytotoxicity, immunogenicity, and limited nucleic acid loading capacity, which hinders efficient gene delivery and expression.
Innovation Solution
A nanoparticle nucleic acid carrier containing hyperbranched polylysine (HBPL) is developed, which forms stable complexes with nucleic acids through electrostatic interactions, enhancing transfection efficiency while reducing cytotoxicity and immunogenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viruses are used as carriers for nucleic acid delivery, then transfection efficiency is improved, but cytotoxicity and immunogenicity increase
Solution Approach 1:
The patent replaces permanent viral vectors with disposable synthetic cationic polymer carriers (hyperbranched polylysine, chitosan, polyamidoamine) that can be synthesized, used, and discarded without the biological complexity and safety issues of viral systems. These synthetic carriers provide transfection efficiency while avoiding the cytotoxicity and immunogenicity of viral vectors.
Solution Approach 2:
The patent introduces cationic polymers as intermediary carriers between the nucleic acid and the cell membrane. These polymers act as mediators that condense nucleic acids into nanoparticles, facilitate cellular uptake, and enable endosomal escape, thereby achieving viral-level transfection efficiency without the harmful biological properties of actual viruses.
2Productivity
If polyethyleneimine (PEI) is used as a cationic polymer carrier, then transfection efficiency is improved, but biological toxicity increases
Solution Approach 1:
The patent modifies the chemical parameters of cationic polymers by using hyperbranched polylysine with controlled molecular weight (20,000-80,000 Da) and specific lysine content (20-40%), chitosan with controlled degree of deacetylation (70-90%), and polyamidoamine with controlled generation and amino nitrogen content. These parameter optimizations maintain transfection efficiency while reducing cytotoxicity compared to conventional PEI.
Solution Approach 2:
The patent employs composite nanoparticle formulations combining cationic polymers with nucleic acids, and in some embodiments, further combines multiple polymers or adds surface-modifying agents to create composite carriers that optimize both transfection efficiency and biocompatibility, reducing the toxicity inherent in simple cationic polymer systems.
3Ease of manufacture
If poly(dimethylaminoethyl methacrylate) (PDMAEMA) is used as a cationic polymer, then ease of modification is improved, but transfection efficiency decreases due to low charge density
Solution Approach 1:
The patent optimizes the charge density parameter by selecting cationic polymers with sufficient positive charge at physiological pH. Hyperbranched polylysine provides high charge density through protonated amino groups, chitosan provides adequate charge through protonated amino groups at acidic endosomal pH, and polyamidoamine provides charge through tertiary and secondary amines, all achieving transfection efficiency superior to PDMAEMA.
4Device complexity
If naked nucleic acid is used for gene delivery, then simplicity is improved, but cellular uptake and stability decrease
Solution Approach 1:
The patent applies the nesting principle by condensing nucleic acids into the core of polymer-nucleic acid nanoparticles, where the cationic polymer forms an outer shell around the negatively charged nucleic acid core. This nested structure protects the nucleic acid from degradation, concentrates it for efficient cellular uptake, and simplifies delivery compared to naked nucleic acid while dramatically improving stability and transfection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The HBPL-based nanoparticle carrier achieves higher transfection rates and lower cytotoxicity compared to traditional carriers like polyethyleneimine (PEI), with stable nanoparticles effectively protecting nucleic acids from enzymatic degradation and facilitating their intracellular delivery.
Implementation Method 1
can be bonded with the loaded nucleic acid substance through electrostatic action to form stable nanoparticles
Implementation Method 2
the nanoparticles are free from enzymatic degradation and immunological recognition clearance
Data Source
AI summary
A nanoparticle nucleic acid carrier containing hyperbranched polylysine (HBPL) and use thereof provided, which relate to the field of biomaterials. The nucleic acid carrier can be bonded with nucleic acid substances through an electrostatic action to form stable nanoparticles, and the preparation method and application means are both convenient and easy to implement, and the repeatability is high. The nanoparticle nucleic acid carrier containing hyperbranched polylysine provided by the present disclosure has a lower cytotoxicity, can successfully load nucleic acid substances into cells, and obtain a higher transfection rate; moreover, compared with the existing optimal gene transfection carrier, polyethyleneimine (PEI), the nucleic acid carrier can show a higher transfection rate and a lower cytotoxicity, and has good application prospects in the fields of gene therapy, nucleic acid vaccines and the like.